STOCK TITAN

Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Insmed to present at Goldman Sachs Annual Global Healthcare Conference
Positive
  • Insmed management to present at prestigious healthcare conference
Negative
  • None.

BRIDGEWATER, N.J., June 7, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA, on Wednesday, June 14, 2023 at 1:20 p.m. PT (4:20 p.m. ET).

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

(PRNewsfoto/Insmed Incorporated)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-goldman-sachs-44th-annual-global-healthcare-conference-301844214.html

SOURCE Insmed Incorporated

FAQ

What is Insmed Incorporated?

Insmed is a global biopharmaceutical company focused on treating serious and rare diseases.

What is the Goldman Sachs Annual Global Healthcare Conference?

The conference is a prestigious event that brings together healthcare industry leaders.

When and where will the fireside chat take place?

The fireside chat will take place on Wednesday, June 14, 2023, at 1:20 p.m. PT in Dana Point, CA.

Can I watch the fireside chat online?

Yes, the webcast will be available on Insmed's investor relations section of their website at www.insmed.com.

How long will the webcast be available?

The webcast will be archived for 30 days after the live event.

Insmed, Inc.

NASDAQ:INSM

INSM Rankings

INSM Latest News

INSM Stock Data

12.06B
178.90M
0.91%
108.31%
7.66%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BRIDGEWATER